Blinatumomab vs historical standard therapy of adult relapsed/refractory acute lymphoblastic leukemia

por Gökbuget, N, Kelsh, M, Chia, V, Advani, A, Bassan, R, Dombret, H, Doubek, M, Fielding, A K, Giebel, S, Haddad, V, Hoelzer, D, Holland, C, Ifrah, N, Katz, A, Maniar, T, Martinelli, G, Morgades, M, O'Brien, S, Ribera, J-M, Rowe, J M, Stein, A, Topp, M, Wadleigh, M, Kantarjian, H
Publicado 2016

Frequency and clinical impact of CDKN2A/ARF/CDKN2B gene deletions as assessed by in-depth genetic analyses in adult T cell acute lymphoblastic leukemia

por Genescà, E., Lazarenkov, A., Morgades, M., Berbis, G., Ruíz-Xivillé, N., Gómez-Marzo, P., Ribera, J., Juncà, J., González-Pérez, A., Mercadal, S., Guardia, R., Artola, M. T., Moreno, M. J., Martínez-López, J., Zamora, L., Barba, P., Gil, C., Tormo, M., Cladera, A., Novo, A., Pratcorona, M., Nomdedeu, J., González-Campos, J., Almeida, M., Cervera, J., Montesinos, P., Batlle, M., Vives, S., Esteve, J., Feliu, E., Solé, F., Orfao, A., Ribera, J. M.
Publicado 2018

P1702: IMPACT OF CENTER CHARACTERISTICS AND MACROECONOMIC FACTORS ON THE OUTCOME OF ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA TREATED WITH PEDIATRIC-INSPIRED PROTOCOLS

por Barba, P., Morgades, M., Montesinos, P., Gonzalez Campos, J., Torrent, A., Gil, C., Bernal, T., Tormo, M., Mercadal, S., Saumell, S., García-Cadenas, I., Queipo de Llano, M., Cervera, M., Coll, R., Bermudez, A., Amigo, M., Monsalvo, S., Esteve, J., Garcia Boyero, R., Novo, A., Hernandez Rivas, J., Cladera, A., Martinez-Sanchez, P., Serrano, J., Artola, M. T., Soria, B., Abella, E., Vall-Llobera, F., Bergua, J., Herrera, P., Barrios, D., Ribera, J. M.
Publicado 2022